0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Editorial |  April 10, 2013
Molecular Testing in Thyroid Cancer:  BRAF Mutation Status and Mortality
Anne R. Cappola, MD, ScM; Susan J. Mandel, MD, MPH
JAMA. 2013;309(14):1529-1530. doi:10.1001/jama.2013.3620.
Original Contribution |  April 10, 2013
Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer
Mingzhao Xing, MD, PhD; Ali S. Alzahrani, MD; Kathryn A. Carson, ScM; et al.
JAMA. 2013;309(14):1493-1501. doi:10.1001/jama.2013.3190.
INCLUDES: , Supplemental Content
JAMA Clinical Challenge |  February 13, 2013 FREE
Unilateral Proptosis
Javier Munoz, MD; Razelle Kurzrock, MD
JAMA. 2013;309(6):605-606. doi:10.1001/jama.2013.233.
JAMA Clinical Challenge |  September 12, 2012 FREE
Short Fourth and Fifth Metacarpals
Nayan Desai, MD; Ankur Kalra, MD
JAMA. 2012;308(10):1034-1035. doi:10.1001/2012.jama.11065.
Lab Reports |  January 04, 2012
Target for Thyroid Cancer
Tracy Hampton, PhD
JAMA. 2012;307(1):24. doi:10.1001/jama.2011.1907.
Original Contribution |  August 17, 2011 FREE
Use of Radioactive Iodine for Thyroid Cancer
Megan R. Haymart, MD; Mousumi Banerjee, PhD; Andrew K. Stewart, MA; et al.
JAMA. 2011;306(7):721-728. doi:10.1001/jama.2011.1139.
JAMA Patient Page |  July 20, 2011 FREE
Hyperthyroidism
Janet M. Torpy, MD; Cassio Lynm, MA; Robert M. Golub, MD
JAMA. 2011;306(3):330. doi:10.1001/jama.306.3.330.
INCLUDES: , Supplemental Content
Original Contribution |  January 05, 2011 FREE
DICER1 Mutations in Familial Multinodular Goiter With and Without Ovarian Sertoli-Leydig Cell Tumors
Thomas Rio Frio, PhD; Amin Bahubeshi, BSc; Chryssa Kanellopoulou, PhD; et al.
JAMA. 2011;305(1):68-77. doi:10.1001/jama.2010.1910.
INCLUDES: , Supplemental Content
Capitol Health Call |  December 08, 2010
Radioactive Risk?
Mike Mitka
JAMA. 2010;304(22):2471. doi:10.1001/jama.2010.1755.
JAMA Patient Page |  September 22, 2010 FREE
Subclinical Hypothyroidism
Ryszard M. Pluta, MD, PhD; Alison E. Burke, MA; Richard M. Glass, MD
JAMA. 2010;304(12):1402. doi:10.1001/jama.304.12.1402.
INCLUDES: , Supplemental Content

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Surgery
Original Article  |  May 15, 2013
Factors That Influence Parathyroid Hormone Half-life:  Determining if New Intraoperative Criteria Are Needed
Andrew J. Leiker, BS; Tina W. F. Yen, MD, MS; Dan C. Eastwood, MS; et al.
JAMA Surgery
Invited Critique  |  May 15, 2013
Intraoperative Parathyroid Hormone Criteria: The Quest for Perfection:  Comment on “Factors That Influence Parathyroid Hormone Half-life”
Kelly L. McCoy, MD; Sally E. Carty, MD
JAMA Dermatology
Correspondence  |  April 01, 2013
The Possibility That Multiple Mucocutaneous (Palisaded Encapsulated and Nonencapsulated) Neuromas May Be a Distinct Entity
Noriyuki Misago, MD; Keiichiro Joh, PhD; Hidenobu Soejima, MD, PhD; et al.
JAMA Otolaryngology–Head & Neck Surgery
Clinical Note  |  April 01, 2013
Occult Multifocal Papillary Thyroid Microcarcinoma Presenting as a Supraclavicular Mass Containing Anaplastic Thyroid Carcinoma
Michael Deutschmann, MD; Moosa Khalil, MBBCh, FRCPC; Shelly Bhayana, MD, MSc, FRCPC; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems